» Articles » PMID: 37422949

Generation of a Human Tropomyosin 1 Knockout IPSC Line

Overview
Journal Stem Cell Res
Publisher Elsevier
Specialty Cell Biology
Date 2023 Jul 9
PMID 37422949
Authors
Affiliations
Soon will be listed here.
Abstract

The CHOPWT17_TPM1KOc28 iPSC line was generated to interrogate the functions of Tropomyosin 1 (TPM1) in primary human cell development. This line was reprogrammed from a previously published wild type control iPSC line.

Citing Articles

Generation of a fluorescent mNeonGreen insulin reporter line in the H1 (WA01) hESC background.

Leavens K, Osorio-Quintero C, Yeuteuh E, Perez-Profeta F, Dattoli A, Cardenas-Diaz F Stem Cell Res. 2024; 81():103559.

PMID: 39276530 PMC: 11719772. DOI: 10.1016/j.scr.2024.103559.


Tropomyosin 1 deficiency facilitates cell state transitions and enhances hemogenic endothelial cell specification during hematopoiesis.

Wilken M, Fonar G, Qiu R, Bennett L, Tober J, Nations C Stem Cell Reports. 2024; 19(9):1264-1276.

PMID: 39214082 PMC: 11411305. DOI: 10.1016/j.stemcr.2024.08.001.

References
1.
Telezhkin V, Schnell C, Yarova P, Yung S, Cope E, Hughes A . Forced cell cycle exit and modulation of GABAA, CREB, and GSK3β signaling promote functional maturation of induced pluripotent stem cell-derived neurons. Am J Physiol Cell Physiol. 2016; 310(7):C520-41. DOI: 10.1152/ajpcell.00166.2015. View

2.
Leavens K, Liao C, Gagne A, Kishore S, Cardenas-Diaz F, French D . Generation of a double insulin and somatostatin reporter line, SCSe001-A-3, for the advancement of stem cell-derived pancreatic islets. Stem Cell Res. 2020; 50:102112. PMC: 8546798. DOI: 10.1016/j.scr.2020.102112. View

3.
Gunning P, Hardeman E . Tropomyosins. Curr Biol. 2017; 27(1):R8-R13. DOI: 10.1016/j.cub.2016.11.033. View

4.
Thom C, Jobaliya C, Lorenz K, Maguire J, Gagne A, Gadue P . Tropomyosin 1 genetically constrains in vitro hematopoiesis. BMC Biol. 2020; 18(1):52. PMC: 7227211. DOI: 10.1186/s12915-020-00783-7. View

5.
An H, Gagne A, Maguire J, Pavani G, Abdulmalik O, Gadue P . The use of pluripotent stem cells to generate diagnostic tools for transfusion medicine. Blood. 2022; 140(15):1723-1734. PMC: 9707399. DOI: 10.1182/blood.2022015883. View